Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Experimental Hematology
|
September 1, 1985
Relapse of host leukemic lymphoblasts following engraftment by an HLA-mismatched marrow transplant: mechanisms of escape from the "graft versus leukemia" effect
P M Sondel, J A Hank, J Molenda, et al.
Cancer Treatment Reports
|
April 1, 1985
Clinical trial depleting T lymphocytes from donor marrow for matched and mismatched allogeneic bone marrow transplants
M E Trigg, R Billing, P M Sondel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1993
Phase I clinical trial of carboplatin and 41.8 degrees C whole-body hyperthermia in cancer patients
H I Robins, J D Cohen, C L Schmitt, et al.
Experimental Hematology
|
December 1, 1985
Transplantation of HLA-haploidentical T-cell-depleted marrow for leukemia: addition of cytosine arabinoside to the pretransplant conditioning prevents rejection
M J Bozdech, P M Sondel, M E Trigg, et al.
Leukemia Research
|
September 21, 2000
Phase II trial of 2-chlorodeoxyadenosine in patients with relapsed/refractory acute myeloid leukemia: a study of the Eastern Cooperative Oncology Group (ECOG), E5995
M S Gordon, M L Young, M S Tallman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1997
Phase I clinical trial of melphalan and 41.8 degrees C whole-body hyperthermia in cancer patients
H I Robins, D Rushing, M Kutz, et al.
Cancer Chemotherapy and Pharmacology
|
April 1, 1999
A pilot study of melphalan, tumor necrosis factor-alpha and 41.8 degrees C whole-body hyperthermia
H I Robins, D M Katschinski, W Longo, et al.
Oncology
|
May 22, 2003
A Systemic Hyperthermia Oncologic Working Group trial. Ifosfamide, carboplatin, and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcoma
A M Westermann, G J Wiedemann, E Jager, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1997
Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein versus granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for non-Hodgkin's lymphoma: results of a randomized double-blind trial
J M Vose, A N Pandite, R A Beveridge, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Experimental Hematology
|
September 1, 1985
Relapse of host leukemic lymphoblasts following engraftment by an HLA-mismatched marrow transplant: mechanisms of escape from the "graft versus leukemia" effect
P M Sondel, J A Hank, J Molenda, et al.
Cancer Treatment Reports
|
April 1, 1985
Clinical trial depleting T lymphocytes from donor marrow for matched and mismatched allogeneic bone marrow transplants
M E Trigg, R Billing, P M Sondel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1993
Phase I clinical trial of carboplatin and 41.8 degrees C whole-body hyperthermia in cancer patients
H I Robins, J D Cohen, C L Schmitt, et al.
Experimental Hematology
|
December 1, 1985
Transplantation of HLA-haploidentical T-cell-depleted marrow for leukemia: addition of cytosine arabinoside to the pretransplant conditioning prevents rejection
M J Bozdech, P M Sondel, M E Trigg, et al.
Leukemia Research
|
September 21, 2000
Phase II trial of 2-chlorodeoxyadenosine in patients with relapsed/refractory acute myeloid leukemia: a study of the Eastern Cooperative Oncology Group (ECOG), E5995
M S Gordon, M L Young, M S Tallman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1997
Phase I clinical trial of melphalan and 41.8 degrees C whole-body hyperthermia in cancer patients
H I Robins, D Rushing, M Kutz, et al.
Cancer Chemotherapy and Pharmacology
|
April 1, 1999
A pilot study of melphalan, tumor necrosis factor-alpha and 41.8 degrees C whole-body hyperthermia
H I Robins, D M Katschinski, W Longo, et al.
Oncology
|
May 22, 2003
A Systemic Hyperthermia Oncologic Working Group trial. Ifosfamide, carboplatin, and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcoma
A M Westermann, G J Wiedemann, E Jager, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1997
Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein versus granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for non-Hodgkin's lymphoma: results of a randomized double-blind trial
J M Vose, A N Pandite, R A Beveridge, et al.
Page
of 3